People · Operator

Struan H. Coleman

Named in public records as an officer, director or promoter · active 2013–2023 · Other

1
Companies
14
Filings
$50.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
CyMedica Orthopedics, Inc.OtherSeries B$50.0M$108.9M2013
Operator network

Struan H. Coleman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Alexander B. Suh · 3 companies · 1 sharedAlexander B. SuhEdwin F. Scheetz · 3 companies · 1 sharedEdwin F. ScheetzChristopher B. Martin · 2 companies · 1 sharedChristopher B. Ma…D. Ronald Yagoda · 2 companies · 1 sharedD. Ronald YagodaRobert Morocco · 2 companies · 1 sharedRobert MoroccoChristopher H. Martin · 1 companies · 1 sharedChristopher H. Ma…Edwin F. Sheetz · 1 companies · 1 sharedEdwin F. SheetzJeff F. Zywicki · 1 companies · 1 sharedJeff F. ZywickiJeffrey T. Zywicki · 1 companies · 1 sharedJeffrey T. ZywickiKelley T. Lipman · 1 companies · 1 sharedKelley T. LipmanRhonda F. Anderson · 1 companies · 1 sharedRhonda F. AndersonRhonda T. Anderson · 1 companies · 1 sharedRhonda T. AndersonWilliam H. Hanna · 1 companies · 1 sharedWilliam H. HannaCyMedica Orthopedics, Inc. · $50.0M raisedCyMedica Orthopedics,…Struan H. ColemanSC
Struan H. Coleman Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Struan H. Coleman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Alexander B. Suh13
Edwin F. Scheetz13
Robert Morocco12
Christopher B. Martin12
D. Ronald Yagoda12
Rhonda F. Anderson11
Jeffrey T. Zywicki11
Kelley T. Lipman11
Rhonda T. Anderson11
Edwin F. Sheetz11
Jeff F. Zywicki11
William H. Hanna11
Christopher H. Martin11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.